Fieldview Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$722K Buy
45,101
+34,322
+318% +$549K 0.11% 215
2025
Q1
$184K Buy
+10,779
New +$184K 0.03% 387